Lymphoma News and Research

RSS
Lymphoma is cancer that begins in cells of the immune system. There are two basic categories of lymphomas. One kind is Hodgkin lymphoma, which is marked by the presence of a type of cell called the Reed-Sternberg cell. The other category is non-Hodgkin lymphomas, which includes a large, diverse group of cancers of immune system cells. Non-Hodgkin lymphomas can be further divided into cancers that have an indolent (slow-growing) course and those that have an aggressive (fast-growing) course. These subtypes behave and respond to treatment differently. Both Hodgkin and non-Hodgkin lymphomas can occur in children and adults, and prognosis and treatment depend on the stage and the type of cancer.
Cell nucleus may play role in enabling cells to evade crowded environments

Cell nucleus may play role in enabling cells to evade crowded environments

A strategic collaboration to speed up the development of allogeneic cell therapies

A strategic collaboration to speed up the development of allogeneic cell therapies

Moffitt study uncovers how specific molecules promote cancer progression

Moffitt study uncovers how specific molecules promote cancer progression

Researchers are developing a new class of compounds against various cancers

Researchers are developing a new class of compounds against various cancers

CAR NKT cells offer a promising approach to combat hard-to-treat solid tumors

CAR NKT cells offer a promising approach to combat hard-to-treat solid tumors

Study shows how mutations in VAV1 gene may promote T-cell tumors in experimental mice

Study shows how mutations in VAV1 gene may promote T-cell tumors in experimental mice

A new therapeutic approach for Epstein-Barr virus-associated tumors

A new therapeutic approach for Epstein-Barr virus-associated tumors

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

Novel radioimmunotherapy proven effective in reversing resistance to lymphoma therapy

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

FDA awards six clinical trial research grants to enhance development of therapies for rare diseases

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

CAR T cell therapy can predict treatment response in patients with large B-cell lymphoma

CAR T cell therapy can predict treatment response in patients with large B-cell lymphoma

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Calibr's novel 'switchable' CAR-T cell therapy granted FDA's Fast Track designation

Researchers identify a potential target for small cell lung cancer

Researchers identify a potential target for small cell lung cancer

FDA releases final guidance to improve patient communication about risks of breast implants

FDA releases final guidance to improve patient communication about risks of breast implants

Researchers decipher how the immune system memorizes pathogens after an infection

Researchers decipher how the immune system memorizes pathogens after an infection

NCCN publishes new clinical practice guidelines for pediatric Hodgkin lymphoma

NCCN publishes new clinical practice guidelines for pediatric Hodgkin lymphoma

Challenges in High Complexity Flow Cytometry

Challenges in High Complexity Flow Cytometry

NCCN's first patient and caregiver resource focused on childhood leukemia

NCCN's first patient and caregiver resource focused on childhood leukemia

Research consortium receives $111 million NCI grant to prevent, treat HIV-related cancers

Research consortium receives $111 million NCI grant to prevent, treat HIV-related cancers

Research uncovers potential cause of neurotoxicity due to immunotherapy

Research uncovers potential cause of neurotoxicity due to immunotherapy